Endoscopic Devices - EMEA

  • EMEA
  • Revenue in the Endoscopic Devices market market in EMEA is projected to reach US$11.00bn in 2024.
  • This revenue is expected to exhibit an annual growth rate (CAGR 2024-2029) of 7.20%, which will result in a market volume of US$15.57bn by 2029.
  • In comparison to the global market, the United States will generate the majority of revenue, totaling US$10,390.00m in 2024.
  • The EMEA region is witnessing a significant rise in demand for advanced endoscopic devices, driven by increasing surgical procedures and a focus on minimally invasive techniques.

Key regions: Italy, United Kingdom, Netherlands, Germany, Japan

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Endoscopic Devices Market within the Medical Devices sector in EMEA is witnessing moderate growth, influenced by factors such as technological advancements, an increasing prevalence of chronic diseases, and heightened demand for minimally invasive procedures among healthcare providers.

Customer preferences:
Consumers are showing a growing preference for advanced endoscopic procedures that promise quicker recovery times and reduced postoperative discomfort, reflecting a broader trend towards patient-centric care. This shift is particularly evident among younger demographics who prioritize minimally invasive options and value the latest technological innovations. Additionally, the increasing awareness of chronic diseases across various cultural backgrounds is driving demand for more sophisticated endoscopic devices, influencing healthcare providers to adopt these advanced solutions to enhance patient outcomes.

Trends in the market:
In the EMEA region, the Endoscopic Devices Market is experiencing a significant shift towards advanced imaging technologies and minimally invasive surgical techniques. Healthcare providers are increasingly adopting high-definition endoscopes and robotic-assisted systems, which enhance precision and improve patient outcomes. Additionally, there is a notable rise in training programs for healthcare professionals focused on these technologies, reflecting a commitment to innovation. This trend is crucial as it aligns with the growing demand for quicker recovery times and enhanced patient experiences, ultimately influencing investment strategies and product development for industry stakeholders.

Local special circumstances:
In the EMEA region, the Endoscopic Devices Market is shaped by diverse healthcare systems and varying levels of technological adoption across countries. For instance, Western European nations prioritize high-quality healthcare and have robust reimbursement frameworks, facilitating the adoption of advanced endoscopic technologies. In contrast, Eastern European countries face budget constraints, impacting investment in innovative devices. Additionally, cultural attitudes towards surgery and patient safety significantly influence the acceptance of minimally invasive techniques, driving demand for training and education among healthcare professionals.

Underlying macroeconomic factors:
The Endoscopic Devices Market in the EMEA region is significantly influenced by macroeconomic factors such as healthcare spending, regulatory policies, and economic stability. Countries with strong national economies and favorable fiscal policies tend to allocate higher budgets for healthcare innovation, enabling the adoption of advanced endoscopic technologies. Conversely, nations facing economic challenges may prioritize essential services over technological investments, stunting market growth. Furthermore, the rising prevalence of gastrointestinal disorders and the emphasis on cost-effective healthcare solutions bolster demand for minimally invasive procedures, further propelling the endoscopic devices segment within the medical technology landscape.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)